These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31043584)
1. SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer. Yousafzai NA; Zhou Q; Xu W; Shi Q; Xu J; Feng L; Chen H; Shin VY; Jin H; Wang X Cell Death Dis; 2019 May; 10(5):363. PubMed ID: 31043584 [TBL] [Abstract][Full Text] [Related]
2. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer. Xu W; Wang S; Chen Q; Zhang Y; Ni P; Wu X; Zhang J; Qiang F; Li A; Røe OD; Xu S; Wang M; Zhang R; Zhou J Cell Death Dis; 2014 Feb; 5(2):e1055. PubMed ID: 24525731 [TBL] [Abstract][Full Text] [Related]
3. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells. Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899 [TBL] [Abstract][Full Text] [Related]
4. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047 [TBL] [Abstract][Full Text] [Related]
5. Baicalin attenuates XRCC1-mediated DNA repair to enhance the sensitivity of lung cancer cells to cisplatin. Yin Z; Chen E; Cai X; Gong E; Li Y; Xu C; Ye Z; Cao Z; Pan J J Recept Signal Transduct Res; 2022 Jun; 42(3):215-224. PubMed ID: 33719846 [TBL] [Abstract][Full Text] [Related]
6. SIRT1 suppresses cellular accumulation of β-TrCP E3 ligase via protein degradation. Woo SR; Byun JG; Kim YH; Park ER; Joo HY; Yun M; Shin HJ; Kim SH; Shen YN; Park JE; Park GH; Lee KH Biochem Biophys Res Commun; 2013 Nov; 441(4):831-7. PubMed ID: 24211209 [TBL] [Abstract][Full Text] [Related]
7. Association of DNA Repair and Drug Transporter in Relation to Chemosensitivity in Primary Culture of Thai Gastric Cancer Patients. Wongsirisin P; Limpakan Yamada S; Yodkeeree S; Punfa W; Limtrakul P Biol Pharm Bull; 2018; 41(3):360-367. PubMed ID: 29491212 [TBL] [Abstract][Full Text] [Related]
8. β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H. Cheng Y; Gao WW; Tang HM; Deng JJ; Wong CM; Chan CP; Jin DY Sci Rep; 2016 Mar; 6():23938. PubMed ID: 27029215 [TBL] [Abstract][Full Text] [Related]
9. X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance. Park SY; Lam W; Cheng YC Cancer Res; 2002 Jan; 62(2):459-65. PubMed ID: 11809696 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119 [TBL] [Abstract][Full Text] [Related]
11. Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin. Zhang Z; Sun C; Zhang L; Chi X; Ji J; Gao X; Wang Y; Zhao Z; Liu L; Cao X; Yang Y; Mao W Biomed Pharmacother; 2019 Jan; 109():1541-1546. PubMed ID: 30551406 [TBL] [Abstract][Full Text] [Related]
12. SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin. Shin DH; Choi YJ; Park JW Cancer Res; 2014 Jan; 74(1):298-308. PubMed ID: 24240701 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling. Chen J; Li Y; Li Z; Cao L J Biochem Mol Toxicol; 2020 Apr; 34(4):e22452. PubMed ID: 32052927 [TBL] [Abstract][Full Text] [Related]
14. WRN translocation from nucleolus to nucleoplasm is regulated by SIRT1 and required for DNA repair and the development of chemoresistance. Lee SY; Lee H; Kim ES; Park S; Lee J; Ahn B Mutat Res; 2015 Apr; 774():40-8. PubMed ID: 25801465 [TBL] [Abstract][Full Text] [Related]
15. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300. Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907 [TBL] [Abstract][Full Text] [Related]
16. Fibroblasts from patients with idiopathic pulmonary fibrosis are resistant to cisplatin-induced cell death via enhanced CK2-dependent XRCC1 activity. Im J; Nho RS Apoptosis; 2019 Jun; 24(5-6):499-510. PubMed ID: 30850922 [TBL] [Abstract][Full Text] [Related]
17. Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer. Lee KJ; Piett CG; Andrews JF; Mann E; Nagel ZD; Gassman NR PLoS One; 2019; 14(10):e0223725. PubMed ID: 31596905 [TBL] [Abstract][Full Text] [Related]
18. β-TRCP-mediated AEBP2 ubiquitination and destruction controls cisplatin resistance in ovarian cancer. Zhang Q; Wang W; Gao Q Biochem Biophys Res Commun; 2020 Feb; 523(1):274-279. PubMed ID: 31864706 [TBL] [Abstract][Full Text] [Related]
19. The cAMP signaling system inhibits the repair of γ-ray-induced DNA damage by promoting Epac1-mediated proteasomal degradation of XRCC1 protein in human lung cancer cells. Cho EA; Juhnn YS Biochem Biophys Res Commun; 2012 Jun; 422(2):256-62. PubMed ID: 22575451 [TBL] [Abstract][Full Text] [Related]
20. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair. Li L; Ye S; Yang M; Yu W; Fan Z; Zhang H; Hu J; Liang A; Zhang W Oncol Rep; 2015 Dec; 34(6):2935-42. PubMed ID: 26398583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]